Healthcare Sector Stocks
The Healthcare sector has a total of 1058 stocks, with a combined market cap of $8.61 trillion, total revenue of $4.59 trillion and a weighted average PE ratio of 43.24.
Market Cap
8.61T
Revenue
4.59T
Profits
199.12B
PE Ratio
43.24
Profit Margin
4.34%
Dividend Yield
0.41%
1059 Stocks
| No. | Symbol | Company Name | Market Cap | % Change | Volume | Revenue |
|---|---|---|---|---|---|---|
| 1 | LLY | Eli Lilly and Company | 987.60B | 0.04% | 791,822 | 72.25B |
| 2 | JNJ | Johnson & Johnson | 577.80B | 0.40% | 1,803,769 | 96.36B |
| 3 | ABBV | AbbVie Inc. | 412.65B | -0.51% | 1,209,301 | 62.82B |
| 4 | UNH | UnitedHealth Group Incorporated | 367.39B | -1.15% | 1,506,760 | 449.71B |
| 5 | MRK | Merck & Co., Inc. | 295.84B | 0.15% | 2,333,783 | 65.77B |
| 6 | NVS | Novartis AG | 279.10B | -0.67% | 4,435,647 | 56.58B |
| 7 | AZN | AstraZeneca PLC | 278.15B | 0.69% | 562,275 | 60.44B |
| 8 | NVO | Novo Nordisk A/S | 207.52B | -0.32% | 4,961,117 | 50.57B |
| 9 | AMGN | Amgen Inc. | 189.49B | 1.18% | 363,730 | 37.22B |
| 10 | TMO | Thermo Fisher Scientific Inc. | 181.20B | 3.88% | 459,687 | 45.20B |
| 11 | ABT | Abbott Laboratories | 158.75B | 0.67% | 3,508,458 | 45.13B |
| 12 | GILD | Gilead Sciences, Inc. | 155.83B | 0.37% | 1,486,191 | 29.74B |
| 13 | ISRG | Intuitive Surgical, Inc. | 143.22B | 0.30% | 593,407 | 10.58B |
| 14 | PFE | Pfizer Inc. | 138.67B | -1.58% | 18,184,526 | 63.32B |
| 15 | DHR | Danaher Corporation | 133.16B | 5.12% | 1,465,146 | 24.78B |
| 16 | CVS | CVS Health Corporation | 127.81B | -1.38% | 1,024,233 | 405.62B |
| 17 | VRTX | Vertex Pharmaceuticals Incorporated | 120.95B | 1.74% | 254,398 | 12.22B |
| 18 | SYK | Stryker Corporation | 120.89B | 1.73% | 647,534 | 25.27B |
| 19 | BMY | Bristol-Myers Squibb Company | 112.95B | -0.40% | 4,236,196 | 48.48B |
| 20 | MDT | Medtronic plc | 103.40B | 0.19% | 1,966,778 | 36.36B |
| 21 | GSK | GSK plc | 102.93B | -1.26% | 1,198,380 | 43.29B |
| 22 | SNY | Sanofi | 100.38B | -0.04% | 1,485,066 | 54.60B |
| 23 | MCK | McKesson Corporation | 90.21B | 0.87% | 204,637 | 403.43B |
| 24 | HCA | HCA Healthcare, Inc. | 87.01B | 1.36% | 309,213 | 76.39B |
| 25 | ELV | Elevance Health, Inc. | 84.19B | -1.88% | 313,845 | 200.42B |
| 26 | CI | The Cigna Group | 73.59B | -1.72% | 470,677 | 277.89B |
| 27 | BSX | Boston Scientific Corporation | 66.87B | -1.34% | 3,803,129 | 20.61B |
| 28 | REGN | Regeneron Pharmaceuticals, Inc. | 63.26B | 0.60% | 136,144 | 14.92B |
| 29 | ARGX | argenx SE | 57.55B | -0.24% | 269,419 | 4.74B |
| 30 | COR | Cencora, Inc. | 55.56B | 1.59% | 371,240 | 328.68B |
| 31 | CAH | Cardinal Health, Inc. | 54.36B | 1.39% | 318,591 | 250.74B |
| 32 | EW | Edwards Lifesciences Corporation | 51.75B | 3.36% | 1,446,203 | 6.30B |
| 33 | TAK | Takeda Pharmaceutical Company Limited | 49.92B | -0.63% | 614,317 | 28.34B |
| 34 | MDLN | Medline Inc. | 47.88B | 3.26% | 1,449,677 | 29.14B |
| 35 | IDXX | IDEXX Laboratories, Inc. | 43.93B | 2.89% | 156,783 | 4.45B |
| 36 | HUM | Humana Inc. | 42.77B | -0.81% | 215,534 | 137.20B |
| 37 | BDX | Becton, Dickinson and Company | 40.59B | 2.36% | 447,462 | 22.23B |
| 38 | ALNY | Alnylam Pharmaceuticals, Inc. | 40.03B | 4.05% | 243,472 | 4.29B |
| 39 | TEVA | Teva Pharmaceutical Industries Limited | 39.02B | 0.90% | 1,466,403 | 17.35B |
| 40 | HLN | Haleon plc | 38.82B | 2.79% | 3,661,940 | 14.85B |
| 41 | A | Agilent Technologies, Inc. | 37.15B | 3.85% | 401,976 | 7.23B |
| 42 | WAT | Waters Corporation | 36.48B | 4.03% | 222,993 | 3.77B |
| 43 | NTRA | Natera, Inc. | 36.36B | 8.16% | 628,526 | 2.50B |
| 44 | RVMD | Revolution Medicines, Inc. | 35.58B | -1.27% | 933,326 | - |
| 45 | ZTS | Zoetis Inc. | 32.83B | 1.90% | 1,508,693 | 9.53B |
| 46 | ALC | Alcon Inc. | 32.10B | 2.73% | 505,959 | 10.63B |
| 47 | RPRX | Royalty Pharma plc | 31.43B | -1.39% | 1,313,255 | 2.44B |
| 48 | ONC | BeOne Medicines AG | 31.05B | 1.15% | 56,298 | 5.70B |
| 49 | CNC | Centene Corporation | 30.91B | -0.85% | 1,131,149 | 178.33B |
| 50 | IQV | IQVIA Holdings Inc. | 30.72B | 7.47% | 474,933 | 16.63B |
| 51 | BIIB | Biogen Inc. | 29.45B | 1.17% | 189,857 | 9.94B |
| 52 | GEHC | GE HealthCare Technologies Inc. | 29.45B | 1.59% | 1,107,379 | 20.98B |
| 53 | RMD | ResMed Inc. | 28.23B | 2.22% | 307,263 | 5.54B |
| 54 | DXCM | DexCom, Inc. | 26.88B | 1.09% | 985,138 | 4.82B |
| 55 | ILMN | Illumina, Inc. | 26.63B | 6.72% | 801,031 | 4.39B |
| 56 | VEEV | Veeva Systems Inc. | 26.62B | 2.59% | 580,314 | 3.32B |
| 57 | PHG | Koninklijke Philips N.V. | 25.37B | 0.30% | 484,005 | 20.34B |
| 58 | MRNA | Moderna, Inc. | 24.63B | 1.77% | 1,500,859 | 2.23B |
| 59 | MTD | Mettler-Toledo International Inc. | 24.41B | 4.44% | 116,245 | 4.09B |
| 60 | WST | West Pharmaceutical Services, Inc. | 24.25B | 2.03% | 175,936 | 3.22B |
| 61 | ROIV | Roivant Sciences Ltd. | 23.82B | 2.83% | 1,803,466 | 8.26M |
| 62 | UTHR | United Therapeutics Corporation | 23.37B | 1.16% | 80,139 | 3.17B |
| 63 | INSM | Insmed Incorporated | 22.91B | 3.49% | 698,426 | 819.56M |
| 64 | BNTX | BioNTech SE | 22.85B | -0.31% | 324,521 | 3.23B |
| 65 | DGX | Quest Diagnostics Incorporated | 22.36B | 2.44% | 190,871 | 11.28B |
| 66 | LH | Labcorp Holdings Inc. | 21.67B | 2.18% | 130,351 | 14.14B |
| 67 | INCY | Incyte Corporation | 21.60B | 3.55% | 409,719 | 5.36B |
| 68 | STE | STERIS plc | 20.17B | 1.84% | 148,642 | 5.94B |
| 69 | VTRS | Viatris Inc. | 18.55B | 1.11% | 1,657,567 | 14.56B |
| 70 | GH | Guardant Health, Inc. | 18.40B | 6.07% | 1,033,943 | 1.08B |
| 71 | ZBH | Zimmer Biomet Holdings, Inc. | 17.31B | 2.18% | 394,158 | 8.41B |
| 72 | NBIX | Neurocrine Biosciences, Inc. | 16.68B | 2.75% | 311,627 | 3.10B |
| 73 | GMAB | Genmab A/S | 15.97B | -0.19% | 568,171 | 3.90B |
| 74 | THC | Tenet Healthcare Corporation | 15.76B | 1.13% | 151,928 | 21.46B |
| 75 | ASND | Ascendis Pharma A/S | 14.83B | 0.10% | 93,443 | 998.25M |
| 76 | JAZZ | Jazz Pharmaceuticals plc | 14.54B | 0.64% | 121,847 | 4.44B |
| 77 | MEDP | Medpace Holdings, Inc. | 14.50B | 7.25% | 117,832 | 2.68B |
| 78 | BTSG | BrightSpring Health Services, Inc. | 14.23B | 2.17% | 482,496 | 13.65B |
| 79 | BBIO | BridgeBio Pharma, Inc. | 13.70B | 1.91% | 384,413 | 579.96M |
| 80 | DVA | DaVita Inc. | 13.68B | 1.02% | 86,348 | 13.84B |
| 81 | COO | The Cooper Companies, Inc. | 13.31B | 3.17% | 505,963 | 4.23B |
| 82 | EXEL | Exelixis, Inc. | 13.10B | 1.52% | 366,801 | 2.38B |
| 83 | SOLV | Solventum Corporation | 13.02B | 1.58% | 241,695 | 8.26B |
| 84 | IONS | Ionis Pharmaceuticals, Inc. | 12.72B | 1.29% | 425,555 | 1.06B |
| 85 | FMS | Fresenius Medical Care AG | 12.70B | 0.27% | 119,495 | 22.32B |
| 86 | AXSM | Axsome Therapeutics, Inc. | 12.57B | 0.97% | 154,251 | 708.24M |
| 87 | SNN | Smith & Nephew plc | 12.52B | 2.40% | 442,815 | 6.16B |
| 88 | PEN | Penumbra, Inc. | 12.50B | 0.03% | 64,871 | 1.45B |
| 89 | ALGN | Align Technology, Inc. | 12.39B | 2.65% | 236,435 | 4.10B |
| 90 | ICLR | ICON Public Limited Company | 12.19B | 11.57% | 716,471 | 8.27B |
| 91 | ELAN | Elanco Animal Health Incorporated | 11.96B | 3.30% | 905,408 | 4.89B |
| 92 | MDGL | Madrigal Pharmaceuticals, Inc. | 11.91B | 0.63% | 62,304 | 1.13B |
| 93 | RVTY | Revvity, Inc. | 11.72B | 5.21% | 286,764 | 2.90B |
| 94 | RDY | Dr. Reddy's Laboratories Limited | 11.68B | 0.07% | 894,541 | 3.58B |
| 95 | ARWR | Arrowhead Pharmaceuticals, Inc. | 11.56B | 2.68% | 310,947 | 622.01M |
| 96 | GMED | Globus Medical, Inc. | 11.25B | 3.57% | 215,043 | 3.10B |
| 97 | CYTK | Cytokinetics, Incorporated | 11.13B | 2.44% | 681,567 | 105.82M |
| 98 | SMMT | Summit Therapeutics Inc. | 11.10B | 0.35% | 1,121,235 | - |
| 99 | BMRN | BioMarin Pharmaceutical Inc. | 11.02B | 0.96% | 306,029 | 3.24B |
| 100 | BAX | Baxter International Inc. | 10.72B | 3.23% | 1,435,743 | 11.32B |
| 101 | KRYS | Krystal Biotech, Inc. | 10.36B | 3.27% | 101,857 | 417.30M |
| 102 | MOH | Molina Healthcare, Inc. | 10.28B | 0.38% | 104,786 | 43.10B |
| 103 | PODD | Insulet Corporation | 10.25B | 2.86% | 242,028 | 2.90B |
| 104 | EHC | Encompass Health Corporation | 10.13B | 2.19% | 179,245 | 6.07B |
| 105 | APGE | Apogee Therapeutics, Inc. | 9.97B | 0.08% | 1,746,268 | - |
| 106 | NUVL | Nuvalent, Inc. | 9.76B | 0.06% | 963,213 | - |
| 107 | CRL | Charles River Laboratories International, Inc. | 9.67B | 7.55% | 275,924 | 4.03B |
| 108 | ENSG | The Ensign Group, Inc. | 9.46B | 2.78% | 209,484 | 5.27B |
| 109 | HSIC | Henry Schein, Inc. | 9.39B | 2.92% | 218,310 | 13.38B |
| 110 | TECH | Bio-Techne Corporation | 9.31B | 5.65% | 554,732 | 1.21B |
| 111 | TEM | Tempus AI, Inc. | 9.16B | 4.90% | 2,354,103 | 1.36B |
| 112 | UHS | Universal Health Services, Inc. | 8.87B | 0.46% | 99,152 | 17.76B |
| 113 | BRKR | Bruker Corporation | 8.81B | 5.04% | 420,123 | 3.46B |
| 114 | CORT | Corcept Therapeutics Incorporated | 8.75B | 2.10% | 134,714 | 769.10M |
| 115 | OSCR | Oscar Health, Inc. | 8.74B | -3.01% | 1,712,197 | 13.30B |
| 116 | PRAX | Praxis Precision Medicines, Inc. | 8.70B | 2.19% | 84,178 | 7.46M |
| 117 | ALKS | Alkermes plc | 8.49B | 5.99% | 1,216,243 | 1.56B |
| 118 | HALO | Halozyme Therapeutics, Inc. | 8.40B | 1.68% | 259,958 | 1.51B |
| 119 | KYMR | Kymera Therapeutics, Inc. | 8.34B | 3.23% | 157,761 | 51.48M |
| 120 | IBRX | ImmunityBio, Inc. | 8.19B | 6.83% | 4,927,038 | 140.98M |
| 121 | GKOS | Glaukos Corporation | 8.12B | 2.78% | 118,706 | 551.35M |
| 122 | QGEN | Qiagen N.V. | 7.98B | 3.76% | 908,846 | 2.10B |
| 123 | PTGX | Protagonist Therapeutics, Inc. | 7.92B | 3.56% | 123,622 | 74.06M |
| 124 | ATR | AptarGroup, Inc. | 7.88B | 2.42% | 40,740 | 3.87B |
| 125 | IMVT | Immunovant, Inc. | 7.84B | 1.54% | 202,165 | - |
| 126 | PCVX | Vaxcyte, Inc. | 7.78B | 3.64% | 244,846 | - |
| 127 | ABVX | ABIVAX Société Anonyme | 7.77B | -8.42% | 4,158,659 | 5.67M |
| 128 | TGTX | TG Therapeutics, Inc. | 7.73B | 1.08% | 662,393 | 700.35M |
| 129 | HIMS | Hims & Hers Health, Inc. | 7.70B | 0.91% | 4,469,165 | 2.37B |
| 130 | RGEN | Repligen Corporation | 7.65B | 7.26% | 262,213 | 763.34M |
| 131 | RYTM | Rhythm Pharmaceuticals, Inc. | 7.59B | 4.28% | 273,249 | 217.17M |
| 132 | BIO | Bio-Rad Laboratories, Inc. | 7.49B | 3.49% | 71,439 | 2.59B |
| 133 | SYRE | Spyre Therapeutics, Inc. | 7.46B | -11.50% | 1,876,957 | - |
| 134 | HQY | HealthEquity, Inc. | 7.16B | 0.86% | 158,296 | 1.34B |
| 135 | PTCT | PTC Therapeutics, Inc. | 6.98B | 2.40% | 850,979 | 827.11M |
| 136 | MIRM | Mirum Pharmaceuticals, Inc. | 6.90B | 1.87% | 142,020 | 569.61M |
| 137 | LNTH | Lantheus Holdings, Inc. | 6.83B | -1.10% | 100,396 | 1.55B |
| 138 | LQDA | Liquidia Corporation | 6.76B | 2.65% | 635,937 | 288.07M |
| 139 | AVTR | Avantor, Inc. | 6.53B | 1.38% | 1,557,078 | 6.55B |
| 140 | COGT | Cogent Biosciences, Inc. | 6.45B | 3.98% | 935,295 | - |
| 141 | CNTA | Centessa Pharmaceuticals plc | 6.27B | - | - | 15.00M |
| 142 | SRRK | Scholar Rock Holding Corporation | 6.24B | 1.62% | 627,520 | - |
| 143 | GRFS | Grifols, S.A. | 6.17B | -0.56% | 70,889 | 8.58B |
| 144 | CGON | CG Oncology, Inc. | 6.14B | 5.86% | 237,389 | 5.07M |
| 145 | PACS | PACS Group, Inc. | 6.10B | 3.13% | 356,581 | 5.43B |
| 146 | CHE | Chemed Corporation | 5.92B | 0.77% | 67,625 | 2.54B |
| 147 | BLTE | Belite Bio, Inc | 5.83B | 2.07% | 81,083 | - |
| 148 | LGND | Ligand Pharmaceuticals Incorporated | 5.73B | 2.33% | 108,852 | 274.48M |
| 149 | TWST | Twist Bioscience Corporation | 5.69B | 7.45% | 530,268 | 409.48M |
| 150 | BLCO | Bausch + Lomb Corporation | 5.61B | 3.28% | 57,505 | 5.21B |
| 151 | TFX | Teleflex Incorporated | 5.59B | 1.59% | 42,845 | 2.13B |
| 152 | LEGN | Legend Biotech Corporation | 5.57B | 2.29% | 472,108 | 1.14B |
| 153 | HNGE | Hinge Health, Inc. | 5.53B | 1.50% | 265,820 | 646.34M |
| 154 | AMRX | Amneal Pharmaceuticals, Inc. | 5.46B | 2.70% | 594,764 | 3.05B |
| 155 | XENE | Xenon Pharmaceuticals Inc. | 5.44B | 3.00% | 339,451 | 7.50M |
| 156 | CRSP | CRISPR Therapeutics AG | 5.33B | 2.35% | 479,049 | 4.10M |
| 157 | TVTX | Travere Therapeutics, Inc. | 5.29B | 1.73% | 542,266 | 536.20M |
| 158 | CAI | Caris Life Sciences, Inc. | 5.18B | 4.15% | 389,118 | 907.29M |
| 159 | ORKA | Oruka Therapeutics, Inc. | 5.15B | 2.40% | 410,125 | - |
| 160 | INDV | Indivior Pharmaceuticals, Inc. | 5.03B | 3.19% | 565,219 | 1.29B |
| 161 | DNTH | Dianthus Therapeutics, Inc. | 4.97B | 3.83% | 334,380 | 1.34M |
| 162 | BLLN | BillionToOne, Inc. | 4.94B | 3.09% | 487,952 | 354.54M |
| 163 | DFTX | Definium Therapeutics, Inc. | 4.83B | 22.37% | 7,246,376 | - |
| 164 | ERAS | Erasca, Inc. | 4.73B | 0.93% | 1,447,677 | - |
| 165 | SHC | Sotera Health Company | 4.69B | 3.72% | 1,585,149 | 1.19B |
| 166 | MANE | Veradermics, Incorporated | 4.67B | 7.92% | 307,744 | - |
| 167 | CELC | Celcuity Inc. | 4.65B | 5.66% | 272,369 | - |
| 168 | STVN | Stevanato Group S.p.A. | 4.64B | 0.83% | 93,003 | 1.39B |
| 169 | KNSA | Kiniksa Pharmaceuticals International, plc | 4.63B | 1.14% | 297,482 | 754.05M |
| 170 | RGC | Regencell Bioscience Holdings Limited | 4.61B | -15.97% | 214,726 | - |
| 171 | ALHC | Alignment Healthcare, Inc. | 4.61B | 2.91% | 403,274 | 4.26B |
| 172 | VCYT | Veracyte, Inc. | 4.57B | 6.56% | 356,252 | 541.74M |
| 173 | RDNT | RadNet, Inc. | 4.51B | 2.15% | 128,543 | 2.14B |
| 174 | EWTX | Edgewise Therapeutics, Inc. | 4.44B | 6.36% | 202,513 | - |
| 175 | LIVN | LivaNova PLC | 4.41B | 2.14% | 133,688 | 1.43B |
| 176 | TXG | 10x Genomics, Inc. | 4.34B | 7.31% | 557,435 | 638.78M |
| 177 | VKTX | Viking Therapeutics, Inc. | 4.27B | 5.69% | 1,500,903 | - |
| 178 | NVST | Envista Holdings Corporation | 4.25B | 3.33% | 240,499 | 2.81B |
| 179 | TNGX | Tango Therapeutics, Inc. | 4.23B | 2.89% | 1,068,650 | 56.99M |
| 180 | MMED | MiniMed Group, Inc. | 4.17B | 8.01% | 262,127 | 3.10B |
| 181 | MMSI | Merit Medical Systems, Inc. | 4.11B | 2.45% | 161,359 | 1.54B |
| 182 | RLAY | Relay Therapeutics, Inc. | 4.08B | 7.40% | 1,243,832 | 10.68M |
| 183 | DNLI | Denali Therapeutics Inc. | 4.05B | 2.91% | 323,599 | - |
| 184 | ACAD | ACADIA Pharmaceuticals Inc. | 4.02B | 3.98% | 358,989 | 1.10B |
| 185 | CRNX | Crinetics Pharmaceuticals, Inc. | 3.89B | 2.67% | 365,144 | 18.07M |
| 186 | CPRX | Catalyst Pharmaceuticals, Inc. | 3.84B | -0.02% | 227,395 | 596.96M |
| 187 | DOCS | Doximity, Inc. | 3.83B | 2.25% | 542,728 | 644.86M |
| 188 | NAMS | NewAmsterdam Pharma Company N.V. | 3.82B | 4.08% | 180,650 | 22.57M |
| 189 | LFST | LifeStance Health Group, Inc. | 3.78B | 3.34% | 601,029 | 1.49B |
| 190 | CON | Concentra Group Holdings Parent, Inc. | 3.76B | 2.44% | 137,612 | 2.23B |
| 191 | TLX | Telix Pharmaceuticals Limited | 3.70B | 7.25% | 84,100 | 803.79M |
| 192 | RCUS | Arcus Biosciences, Inc. | 3.67B | 3.48% | 354,991 | 236.00M |
| 193 | IRTC | iRhythm Holdings, Inc. | 3.66B | 1.04% | 62,694 | 787.85M |
| 194 | WAY | Waystar Holding Corp. | 3.64B | 3.10% | 553,425 | 1.16B |
| 195 | BEAM | Beam Therapeutics Inc. | 3.55B | 7.38% | 968,869 | 164.01M |
| 196 | BKD | Brookdale Senior Living Inc. | 3.54B | 7.01% | 1,434,968 | 3.00B |
| 197 | OGN | Organon & Co. | 3.53B | 0.07% | 630,081 | 6.16B |
| 198 | ICUI | ICU Medical, Inc. | 3.50B | 3.37% | 80,760 | 2.16B |
| 199 | PBLS | Parabilis Medicines, Inc. | 3.49B | -0.40% | 151,111 | - |
| 200 | DYN | Dyne Therapeutics, Inc. | 3.48B | 3.90% | 450,524 | - |
| 201 | OPCH | Option Care Health, Inc. | 3.46B | 0.27% | 395,125 | 5.67B |
| 202 | ARQT | Arcutis Biotherapeutics, Inc. | 3.45B | 4.95% | 299,507 | 415.62M |
| 203 | GPCR | Structure Therapeutics Inc. | 3.38B | 4.19% | 162,711 | - |
| 204 | HAE | Haemonetics Corporation | 3.30B | -0.37% | 72,404 | 1.33B |
| 205 | WRBY | Warby Parker Inc. | 3.27B | 3.96% | 716,475 | 890.57M |
| 206 | IDYA | IDEAYA Biosciences, Inc. | 3.24B | 5.56% | 579,907 | 225.27M |
| 207 | ALMS | Alumis Inc. | 3.17B | 1.39% | 190,329 | 8.40M |
| 208 | NHC | National HealthCare Corporation | 3.15B | 1.21% | 26,532 | 1.53B |
| 209 | QURE | uniQure N.V. | 3.11B | 0.62% | 2,215,754 | 18.09M |
| 210 | ITGR | Integer Holdings Corporation | 3.09B | 1.66% | 53,795 | 1.86B |
| 211 | PRVA | Privia Health Group, Inc. | 3.05B | 1.85% | 160,411 | 2.25B |
| 212 | HTFL | HeartFlow, Inc. | 3.02B | 1.42% | 280,699 | 191.42M |
| 213 | ELVN | Enliven Therapeutics, Inc. | 3.01B | 1.81% | 413,235 | - |
| 214 | ADPT | Adaptive Biotechnologies Corporation | 2.98B | 8.18% | 1,195,521 | 295.41M |
| 215 | TARS | Tarsus Pharmaceuticals, Inc. | 2.94B | 3.16% | 209,329 | 535.08M |
| 216 | KLRA | Kailera Therapeutics, Inc. | 2.93B | 5.99% | 89,390 | - |
| 217 | RARE | Ultragenyx Pharmaceutical Inc. | 2.92B | 3.55% | 620,859 | 670.00M |
| 218 | VERA | Vera Therapeutics, Inc. | 2.86B | 4.19% | 551,186 | - |
| 219 | CLOV | Clover Health Investments, Corp. | 2.76B | 3.66% | 1,962,937 | 2.21B |
| 220 | GRAL | GRAIL, Inc. | 2.74B | 4.48% | 140,162 | 156.12M |
| 221 | IRON | Disc Medicine, Inc. | 2.72B | 1.25% | 186,344 | - |
| 222 | TMDX | TransMedics Group, Inc. | 2.67B | 4.70% | 252,992 | 635.89M |
| 223 | CLDX | Celldex Therapeutics, Inc. | 2.63B | 1.67% | 153,497 | 865.00K |
| 224 | ESTA | Establishment Labs Holdings Inc. | 2.62B | 2.24% | 109,140 | 229.58M |
| 225 | SUPN | Supernus Pharmaceuticals, Inc. | 2.61B | 1.15% | 93,663 | 776.83M |
| 226 | TRVI | Trevi Therapeutics, Inc. | 2.54B | 2.76% | 340,741 | - |
| 227 | GRDN | Guardian Pharmacy Services, Inc. | 2.50B | 0.92% | 67,185 | 1.46B |
| 228 | AUPH | Aurinia Pharmaceuticals Inc. | 2.47B | 7.44% | 1,298,799 | 298.30M |
| 229 | AXGN | Axogen, Inc. | 2.41B | 1.61% | 305,947 | 238.11M |
| 230 | BCRX | BioCryst Pharmaceuticals, Inc. | 2.40B | 1.56% | 1,266,066 | 885.72M |
| 231 | PHVS | Pharvaris N.V. | 2.35B | 1.14% | 70,652 | - |
| 232 | KOD | Kodiak Sciences Inc. | 2.32B | 0.50% | 97,456 | - |
| 233 | MBX | MBX Biosciences, Inc. | 2.28B | 3.08% | 212,528 | - |
| 234 | NUVB | Nuvation Bio Inc. | 2.27B | 7.95% | 2,756,071 | 143.05M |
| 235 | BHVN | Biohaven Ltd. | 2.26B | 1.69% | 444,487 | - |
| 236 | ACHC | Acadia Healthcare Company, Inc. | 2.25B | -0.33% | 283,772 | 3.37B |
| 237 | NKTR | Nektar Therapeutics | 2.24B | -0.63% | 226,697 | 55.63M |
| 238 | PBH | Prestige Consumer Healthcare Inc. | 2.23B | 2.19% | 111,727 | 1.09B |
| 239 | NTLA | Intellia Therapeutics, Inc. | 2.22B | 4.26% | 1,227,452 | 66.09M |
| 240 | IMNM | Immunome, Inc. | 2.21B | 0.98% | 258,279 | 4.02M |
| 241 | OCUL | Ocular Therapeutix, Inc. | 2.19B | -1.24% | 607,075 | 52.04M |
| 242 | AGIO | Agios Pharmaceuticals, Inc. | 2.17B | 2.58% | 322,148 | 66.05M |
| 243 | MLYS | Mineralys Therapeutics, Inc. | 2.16B | 2.26% | 235,027 | - |
| 244 | VCEL | Vericel Corporation | 2.14B | 3.99% | 195,933 | 292.09M |
| 245 | LMAT | LeMaitre Vascular, Inc. | 2.11B | 0.64% | 52,558 | 256.28M |
| 246 | PGNY | Progyny, Inc. | 2.11B | 1.24% | 138,778 | 1.29B |
| 247 | XRAY | DENTSPLY SIRONA Inc. | 2.11B | 3.09% | 1,241,204 | 3.68B |
| 248 | GENB | Generate Biomedicines, Inc. | 2.09B | 5.90% | 159,835 | 30.30M |
| 249 | ASTH | Astrana Health, Inc. | 2.09B | 2.11% | 270,970 | 3.53B |
| 250 | BFLY | Butterfly Network, Inc. | 2.09B | 3.91% | 4,243,134 | 102.92M |
| 251 | ZLAB | Zai Lab Limited | 2.07B | -0.43% | 319,443 | 453.28M |
| 252 | NRIX | Nurix Therapeutics, Inc. | 2.06B | 5.41% | 271,553 | 71.78M |
| 253 | SEM | Select Medical Holdings Corporation | 2.06B | 0.09% | 249,129 | 5.52B |
| 254 | ADMA | ADMA Biologics, Inc. | 2.04B | 1.44% | 528,887 | 509.86M |
| 255 | KARD | Kardigan, Inc. | 2.03B | 2.07% | 182,342 | - |
| 256 | TSHA | Taysha Gene Therapies, Inc. | 2.02B | 2.48% | 270,826 | 7.47M |
| 257 | HRMY | Harmony Biosciences Holdings, Inc. | 2.02B | 2.03% | 93,817 | 899.11M |
| 258 | MESO | Mesoblast Limited | 2.00B | 2.15% | 61,755 | 65.38M |
| 259 | RAPP | Rapport Therapeutics, Inc. | 1.99B | 7.07% | 144,842 | 20.00M |
| 260 | NEOG | Neogen Corporation | 1.97B | 2.49% | 242,387 | 870.56M |
| 261 | IOVA | Iovance Biotherapeutics, Inc. | 1.97B | -0.79% | 5,136,245 | 285.61M |
| 262 | STOK | Stoke Therapeutics, Inc. | 1.96B | 1.16% | 125,223 | 32.08M |
| 263 | SGRY | Surgery Partners, Inc. | 1.95B | 3.51% | 213,244 | 3.34B |
| 264 | PGEN | Precigen, Inc. | 1.94B | 1.31% | 1,074,457 | 31.60M |
| 265 | VRDN | Viridian Therapeutics, Inc. | 1.93B | 1.04% | 308,038 | 70.92M |
| 266 | MD | Pediatrix Medical Group, Inc. | 1.92B | 0.46% | 124,115 | 1.93B |
| 267 | LKFT | Lakefront Biotherapeutics NV | 1.90B | 0.07% | 34,558 | 1.20B |
| 268 | WGS | GeneDx Holdings Corp. | 1.89B | 9.44% | 397,863 | 442.68M |
| 269 | AMLX | Amylyx Pharmaceuticals, Inc. | 1.89B | 3.67% | 257,285 | -665.00K |
| 270 | BHC | Bausch Health Companies Inc. | 1.84B | 2.92% | 404,099 | 10.53B |
| 271 | TYRA | Tyra Biosciences, Inc. | 1.84B | 3.16% | 80,613 | - |
| 272 | UFPT | UFP Technologies, Inc. | 1.84B | 1.52% | 79,817 | 608.85M |
| 273 | AVAH | Aveanna Healthcare Holdings Inc. | 1.84B | 2.93% | 488,014 | 2.52B |
| 274 | SRPT | Sarepta Therapeutics, Inc. | 1.83B | 0.38% | 468,659 | 2.18B |
| 275 | ABCL | AbCellera Biologics Inc. | 1.83B | 6.31% | 3,249,789 | 79.21M |
| 276 | PLSE | Pulse Biosciences, Inc. | 1.83B | 1.70% | 40,189 | 751.00K |
| 277 | AGL | agilon health, inc. | 1.82B | -2.17% | 76,946 | 5.82B |
| 278 | SNDX | Syndax Pharmaceuticals, Inc. | 1.82B | 4.69% | 443,805 | 217.17M |
| 279 | SION | Sionna Therapeutics, Inc. | 1.82B | 1.03% | 120,846 | - |
| 280 | SNDA | Sonida Senior Living, Inc. | 1.82B | 6.17% | 245,654 | 367.34M |
| 281 | GLUE | Monte Rosa Therapeutics, Inc. | 1.81B | 3.38% | 474,178 | 42.95M |
| 282 | NBTX | Nanobiotix S.A. | 1.80B | -6.39% | 20,346 | 38.27M |
| 283 | HCM | HUTCHMED (China) Limited | 1.79B | 0.94% | 6,385 | 548.51M |
| 284 | CMPS | COMPASS Pathways plc | 1.79B | 4.66% | 1,426,333 | - |
| 285 | ZYME | Zymeworks Inc. | 1.78B | 2.35% | 80,180 | 81.26M |
| 286 | ADUS | Addus HomeCare Corporation | 1.78B | 1.33% | 35,372 | 1.45B |
| 287 | OMCL | Omnicell, Inc. | 1.77B | 1.48% | 76,885 | 1.23B |
| 288 | ANIP | ANI Pharmaceuticals, Inc. | 1.77B | 0.63% | 100,070 | 923.71M |
| 289 | INVA | Innoviva, Inc. | 1.75B | 0.93% | 84,416 | 420.69M |
| 290 | PVLA | Palvella Therapeutics, Inc. | 1.75B | 3.01% | 35,742 | - |
| 291 | ANAB | AnaptysBio, Inc. | 1.74B | 0.37% | 76,800 | 232.39M |
| 292 | VIR | Vir Biotechnology, Inc. | 1.73B | 1.18% | 549,543 | 65.50M |
| 293 | RXRX | Recursion Pharmaceuticals, Inc. | 1.73B | 3.16% | 5,862,118 | 66.41M |
| 294 | URGN | UroGen Pharma Ltd. | 1.73B | 1.01% | 88,280 | 140.49M |
| 295 | CAPR | Capricor Therapeutics, Inc. | 1.72B | 0.24% | 208,408 | 11.13M |
| 296 | BCAX | Bicara Therapeutics Inc. | 1.71B | 4.00% | 192,516 | - |
| 297 | ALMR | Alamar Biosciences, Inc. | 1.68B | 5.88% | 46,078 | 87.16M |
| 298 | NVCR | NovoCure Limited | 1.68B | 2.48% | 286,040 | 674.41M |
| 299 | GHRS | GH Research PLC | 1.66B | 2.67% | 35,419 | - |
| 300 | SLS | SELLAS Life Sciences Group, Inc. | 1.65B | -1.93% | 1,831,047 | - |
| 301 | SEPN | Septerna, Inc. | 1.64B | -0.72% | 78,163 | 72.26M |
| 302 | FTRE | Fortrea Holdings Inc. | 1.63B | 4.62% | 666,806 | 2.71B |
| 303 | HCSG | Healthcare Services Group, Inc. | 1.62B | 3.93% | 206,891 | 1.85B |
| 304 | NEO | NeoGenomics, Inc. | 1.61B | 8.11% | 815,807 | 745.97M |
| 305 | HROW | Harrow, Inc. | 1.61B | 0.81% | 198,312 | 268.68M |
| 306 | ARDX | Ardelyx, Inc. | 1.57B | 2.59% | 693,543 | 427.68M |
| 307 | TRLV | Trulieve Cannabis Corp. | 1.55B | -5.63% | 1,206,304 | 1.17B |
| 308 | ATAI | AtaiBeckley Inc. | 1.54B | 2.20% | 1,622,730 | 3.49M |
| 309 | AVBP | ArriVent BioPharma, Inc. | 1.53B | -2.50% | 278,496 | - |
| 310 | AKTS | Aktis Oncology, Inc. | 1.52B | 1.81% | 74,118 | 8.28M |
| 311 | IMCR | Immunocore Holdings plc | 1.52B | 2.09% | 231,467 | 412.81M |
| 312 | NVAX | Novavax, Inc. | 1.50B | 1.11% | 985,669 | 596.34M |
| 313 | AAPG | Ascentage Pharma Group International | 1.49B | 0.18% | 2,406 | 82.08M |
| 314 | MAZE | Maze Therapeutics, Inc. | 1.48B | 1.21% | 142,636 | 20.00M |
| 315 | SVRA | Savara Inc. | 1.48B | 0.87% | 351,076 | - |
| 316 | MRVI | Maravai LifeSciences Holdings, Inc. | 1.46B | 5.40% | 581,792 | 204.73M |
| 317 | ATRC | AtriCure, Inc. | 1.46B | 1.27% | 237,065 | 552.16M |
| 318 | DMRA | Damora Therapeutics, Inc. | 1.44B | 2.27% | 101,112 | - |
| 319 | MLTX | MoonLake Immunotherapeutics | 1.44B | -8.11% | 3,106,360 | - |
| 320 | ABSI | Absci Corporation | 1.43B | 23.89% | 19,534,629 | 1.84M |
| 321 | STAA | STAAR Surgical Company | 1.42B | 0.81% | 78,265 | 290.38M |
| 322 | TDOC | Teladoc Health, Inc. | 1.40B | 1.17% | 1,046,352 | 2.51B |
| 323 | INBX | Inhibrx Biosciences, Inc. | 1.39B | 2.34% | 74,890 | 1.30M |
| 324 | IART | Integra LifeSciences Holdings Corporation | 1.39B | 1.24% | 145,550 | 1.64B |
| 325 | ATEC | Alphatec Holdings, Inc. | 1.38B | 5.94% | 856,444 | 787.08M |
| 326 | IMTX | Immatics N.V. | 1.38B | 1.72% | 153,940 | 43.00M |
| 327 | CDNA | CareDx, Inc. | 1.37B | 5.29% | 368,384 | 412.82M |
| 328 | AVLN | Avalyn Pharma Inc. | 1.36B | 0.39% | 32,551 | - |
| 329 | COAG | Hemab Therapeutics Holdings, Inc. | 1.35B | 5.04% | 16,851 | - |
| 330 | ARDT | Ardent Health, Inc. | 1.35B | 2.61% | 57,468 | 6.43B |
| 331 | PRGO | Perrigo Company plc | 1.34B | 2.21% | 377,009 | 4.18B |
| 332 | MPLT | MapLight Therapeutics, Inc. | 1.34B | 3.28% | 73,496 | - |
| 333 | JBIO | Jade Biosciences, Inc. | 1.34B | 2.41% | 320,782 | - |
| 334 | ZBIO | Zenas BioPharma, Inc. | 1.33B | 4.58% | 62,359 | 10.00M |
| 335 | AHCO | AdaptHealth Corp. | 1.33B | 2.89% | 819,350 | 3.29B |
| 336 | INNV | InnovAge Holding Corp. | 1.32B | 4.08% | 86,165 | 949.17M |
| 337 | PAHC | Phibro Animal Health Corporation | 1.30B | 4.75% | 33,844 | 1.50B |
| 338 | XERS | Xeris Biopharma Holdings, Inc. | 1.29B | 3.82% | 426,060 | 314.85M |
| 339 | KMTS | Kestra Medical Technologies, Ltd. | 1.27B | 5.07% | 31,128 | 83.72M |
| 340 | BLFS | BioLife Solutions, Inc. | 1.25B | 3.59% | 323,763 | 101.66M |
| 341 | ALVO | Alvotech | 1.25B | 0.68% | 285,596 | 562.04M |
| 342 | INSP | Inspire Medical Systems, Inc. | 1.24B | 2.97% | 102,560 | 915.25M |
| 343 | ENOV | Enovis Corporation | 1.24B | 1.51% | 338,724 | 2.28B |
| 344 | EYPT | EyePoint, Inc. | 1.23B | 2.23% | 129,913 | 7.61M |
| 345 | PRCT | PROCEPT BioRobotics Corporation | 1.22B | 3.69% | 438,845 | 322.02M |
| 346 | MNKD | MannKind Corporation | 1.22B | 0.13% | 536,173 | 360.78M |
| 347 | IRMD | IRADIMED CORPORATION | 1.22B | 2.92% | 28,060 | 86.28M |
| 348 | AMN | AMN Healthcare Services, Inc. | 1.21B | 0.26% | 133,561 | 3.42B |
| 349 | PNTG | The Pennant Group, Inc. | 1.21B | 1.26% | 45,377 | 1.02B |
| 350 | AHG | Akso Health Group | 1.19B | 2.21% | 7,753 | 14.84M |
| 351 | WVE | Wave Life Sciences Ltd. | 1.17B | 0.75% | 1,217,695 | 71.80M |
| 352 | AVNS | Avanos Medical, Inc. | 1.17B | -0.10% | 109,480 | 715.90M |
| 353 | COLL | Collegium Pharmaceutical, Inc. | 1.16B | 2.95% | 65,437 | 796.33M |
| 354 | SDGR | Schrödinger, Inc. | 1.15B | 2.13% | 332,938 | 254.91M |
| 355 | PSNL | Personalis, Inc. | 1.13B | 7.36% | 1,711,504 | 64.52M |
| 356 | MGTX | MeiraGTx Holdings plc | 1.13B | 3.30% | 222,308 | 79.76M |
| 357 | OPK | OPKO Health, Inc. | 1.13B | 2.40% | 843,843 | 581.12M |
| 358 | CGEM | Cullinan Therapeutics, Inc. | 1.12B | 2.99% | 221,709 | - |
| 359 | OMDA | Omada Health, Inc. | 1.11B | 2.46% | 206,796 | 283.30M |
| 360 | XNCR | Xencor, Inc. | 1.10B | 5.47% | 155,791 | 97.36M |
| 361 | CRVS | Corvus Pharmaceuticals, Inc. | 1.09B | 2.38% | 202,029 | - |
| 362 | AZTA | Azenta, Inc. | 1.08B | 5.36% | 97,142 | 596.48M |
| 363 | SPRY | ARS Pharmaceuticals, Inc. | 1.08B | 5.54% | 511,035 | 98.99M |
| 364 | SPTX | Seaport Therapeutics, Inc. | 1.07B | 5.38% | 39,312 | - |
| 365 | CNMD | CONMED Corporation | 1.06B | 4.01% | 99,369 | 1.37B |
| 366 | SANA | Sana Biotechnology, Inc. | 1.03B | 2.69% | 943,511 | - |
| 367 | AORT | Artivion, Inc. | 1.03B | 2.76% | 129,055 | 458.69M |
| 368 | TNDM | Tandem Diabetes Care, Inc. | 1.03B | 4.09% | 511,538 | 1.03B |
| 369 | NUTX | Nutex Health Inc. | 1.02B | 1.17% | 17,015 | 879.95M |
| 370 | LXRX | Lexicon Pharmaceuticals, Inc. | 1.00B | 4.63% | 1,060,697 | 69.64M |
| 371 | CRON | Cronos Group Inc. | 1.00B | 0.19% | 205,130 | 159.54M |
| 372 | BIOA | BioAge Labs, Inc. | 992.19M | - | 195,592 | 10.32M |
| 373 | USPH | U.S. Physical Therapy, Inc. | 989.18M | 2.36% | 34,137 | 787.69M |
| 374 | OLMA | Olema Pharmaceuticals, Inc. | 988.77M | 7.50% | 347,901 | - |
| 375 | AVR | Anteris Technologies Global Corp. | 987.05M | -1.36% | 513,356 | 1.85M |
| 376 | ORIC | ORIC Pharmaceuticals, Inc. | 968.92M | 5.05% | 256,681 | - |
| 377 | DBVT | DBV Technologies S.A. | 968.08M | -0.50% | 101,567 | 5.74M |
| 378 | KURA | Kura Oncology, Inc. | 961.43M | 4.34% | 351,799 | 71.64M |
| 379 | REPL | Replimune Group, Inc. | 961.15M | 1.93% | 722,409 | - |
| 380 | AVTX | Avalo Therapeutics, Inc. | 956.69M | 2.08% | 153,029 | 59.00K |
| 381 | EVO | Evotec SE | 951.37M | 4.58% | 12,911 | 859.03M |
| 382 | INMD | InMode Ltd. | 940.88M | 11.24% | 1,394,453 | 374.64M |
| 383 | ETON | Eton Pharmaceuticals, Inc. | 937.64M | 2.21% | 121,254 | 86.93M |
| 384 | PCRX | Pacira BioSciences, Inc. | 937.27M | 1.32% | 53,772 | 734.86M |
| 385 | LMRI | Lumexa Imaging Holdings, Inc. | 932.94M | 2.97% | 51,695 | 1.03B |
| 386 | PHAR | Pharming Group N.V. | 931.75M | 2.72% | 2,259 | 369.49M |
| 387 | GDRX | GoodRx Holdings, Inc. | 927.97M | 2.62% | 274,602 | 787.89M |
| 388 | DRTS | Alpha Tau Medical Ltd. | 921.15M | 4.23% | 250,274 | - |
| 389 | ANRO | Alto Neuroscience, Inc. | 918.30M | 7.07% | 65,198 | - |
| 390 | ANNX | Annexon, Inc. | 909.33M | 5.11% | 1,278,293 | - |
| 391 | DSGN | Design Therapeutics, Inc. | 908.75M | 5.90% | 192,452 | - |
| 392 | JANX | Janux Therapeutics, Inc. | 908.67M | -0.07% | 391,308 | 13.73M |
| 393 | EVMN | Evommune, Inc. | 906.22M | 3.75% | 219,155 | 10.00M |
| 394 | ODTX | Odyssey Therapeutics, Inc. | 899.63M | 1.29% | 73,236 | 1.06M |
| 395 | GERN | Geron Corporation | 898.19M | 3.71% | 4,456,307 | 196.12M |
| 396 | LBRX | LB Pharmaceuticals Inc | 897.58M | 2.29% | 70,287 | - |
| 397 | AMPH | Amphastar Pharmaceuticals, Inc. | 893.54M | 3.76% | 105,927 | 720.53M |
| 398 | TBPH | Theravance Biopharma, Inc. | 890.58M | 1.80% | 61,848 | 109.78M |
| 399 | SLDB | Solid Biosciences Inc. | 886.05M | 2.39% | 452,876 | - |
| 400 | PHAT | Phathom Pharmaceuticals, Inc. | 880.88M | 2.12% | 199,461 | 204.89M |
| 401 | ABUS | Arbutus Biopharma Corporation | 872.13M | -0.79% | 581,272 | 191.45M |
| 402 | TALK | Talkspace, Inc. | 870.23M | -0.10% | 674,194 | 238.37M |
| 403 | CERT | Certara, Inc. | 859.49M | 2.31% | 492,593 | 419.75M |
| 404 | QDEL | QuidelOrtho Corporation | 842.84M | 3.56% | 262,505 | 2.66B |
| 405 | ESPR | Esperion Therapeutics, Inc. | 812.20M | -0.16% | 2,659,338 | 418.24M |
| 406 | VOR | Vor Biopharma Inc. | 803.58M | -0.13% | 146,003 | - |
| 407 | AURA | Aura Biosciences, Inc. | 796.36M | 2.85% | 54,425 | - |
| 408 | BVS | Bioventus Inc. | 794.42M | 2.37% | 111,239 | 576.30M |
| 409 | ZVRA | Zevra Therapeutics, Inc. | 776.77M | 1.08% | 233,791 | 122.29M |
| 410 | OMER | Omeros Corporation | 776.59M | 2.39% | 263,962 | 9.89M |
| 411 | HSTM | HealthStream, Inc. | 753.17M | 0.47% | 25,928 | 311.78M |
| 412 | IVA | Inventiva S.A. | 750.68M | -4.04% | 295,837 | 7.94M |
| 413 | GMRS | GMR Solutions Inc. | 749.68M | 4.20% | 150,574 | 5.83B |
| 414 | SIBN | SI-BONE, Inc. | 730.21M | 3.23% | 139,541 | 206.22M |
| 415 | CTMX | CytomX Therapeutics, Inc. | 726.04M | 5.87% | 849,725 | 35.54M |
| 416 | ALLO | Allogene Therapeutics, Inc. | 724.82M | 1.45% | 1,396,030 | 22.00K |
| 417 | RLMD | Relmada Therapeutics, Inc. | 722.69M | 1.77% | 263,608 | - |
| 418 | CBLL | CeriBell, Inc. | 718.63M | 2.99% | 162,041 | 95.07M |
| 419 | CLYM | Climb Bio, Inc. | 707.17M | 0.41% | 502,184 | - |
| 420 | IMMX | Immix Biopharma, Inc. | 704.78M | -0.10% | 207,518 | - |
| 421 | SSII | SS Innovations International, Inc. | 704.46M | 3.53% | 28,955 | 48.47M |
| 422 | OCS | Oculis Holding AG | 700.20M | -1.07% | 82,392 | 1.40M |
| 423 | TENX | Tenax Therapeutics, Inc. | 693.32M | -0.51% | 177,128 | - |
| 424 | CADL | Candel Therapeutics, Inc. | 686.54M | 3.19% | 375,737 | - |
| 425 | CRMD | CorMedix Inc. | 682.14M | 1.10% | 172,519 | 400.05M |
| 426 | ACRS | Aclaris Therapeutics, Inc. | 681.56M | -0.81% | 501,442 | 8.37M |
| 427 | RIGL | Rigel Pharmaceuticals, Inc. | 680.51M | 3.29% | 58,901 | 299.77M |
| 428 | CSTL | Castle Biosciences, Inc. | 671.81M | 3.60% | 95,148 | 339.92M |
| 429 | NNNN | Anbio Biotechnology | 670.00M | -2.77% | 6,158 | 8.65M |
| 430 | FTH | Faeth Therapeutics, Inc. | 664.83M | 7.46% | 31,402 | - |
| 431 | SGP | SpyGlass Pharma, Inc. | 664.19M | 1.02% | 10,797 | - |
| 432 | BBNX | Beta Bionics, Inc. | 661.74M | 8.63% | 146,961 | 110.24M |
| 433 | DRUG | Bright Minds Biosciences Inc. | 655.78M | -0.20% | 59,774 | - |
| 434 | AGMB | AgomAb Therapeutics NV | 655.00M | 11.39% | 60,402 | - |
| 435 | IRWD | Ironwood Pharmaceuticals, Inc. | 651.05M | 2.46% | 370,379 | 361.51M |
| 436 | AQST | Aquestive Therapeutics, Inc. | 629.76M | -0.20% | 569,598 | 50.27M |
| 437 | TRAX | First Tracks Biotherapeutics, Inc. | 625.27M | 0.79% | 54,859 | - |
| 438 | SLBT | SL Science Holding Limited | 623.40M | -2.60% | 45,595 | - |
| 439 | TCMD | Tactile Systems Technology, Inc. | 611.84M | 2.55% | 27,247 | 343.52M |
| 440 | DNA | Ginkgo Bioworks Holdings, Inc. | 608.17M | 5.08% | 317,207 | 151.40M |
| 441 | BBOT | BridgeBio Oncology Therapeutics, Inc. | 602.41M | 0.27% | 106,391 | - |
| 442 | FDMT | 4D Molecular Therapeutics, Inc. | 600.65M | -0.95% | 217,057 | 88.24M |
| 443 | PRME | Prime Medicine, Inc. | 598.75M | 2.31% | 922,724 | 4.03M |
| 444 | PHR | Phreesia, Inc. | 598.34M | 5.79% | 240,388 | 495.59M |
| 445 | TECX | Tectonic Therapeutic, Inc. | 586.27M | 1.57% | 21,154 | - |
| 446 | ALT | Altimmune, Inc. | 584.39M | 3.26% | 1,025,984 | 36.00K |
| 447 | BWAY | BrainsWay Ltd. | 582.36M | -0.76% | 12,118 | 56.22M |
| 448 | CBIO | Crescent Biopharma, Inc. | 581.01M | -0.09% | 25,365 | 11.88M |
| 449 | GYRE | Gyre Therapeutics, Inc. | 574.73M | 2.61% | 17,760 | 117.05M |
| 450 | MNPR | Monopar Therapeutics Inc. | 573.62M | 4.72% | 46,560 | - |
| 451 | NVCT | Nuvectis Pharma, Inc. | 567.65M | 21.94% | 318,552 | - |
| 452 | MDXG | MiMedx Group, Inc. | 567.48M | 2.14% | 235,624 | 389.42M |
| 453 | RGNX | REGENXBIO Inc. | 566.09M | 10.05% | 767,873 | 87.82M |
| 454 | NPCE | NeuroPace, Inc. | 563.06M | 3.74% | 32,964 | 99.53M |
| 455 | CTKB | Cytek Biosciences, Inc. | 559.83M | 6.51% | 333,337 | 204.17M |
| 456 | EVH | Evolent Health, Inc. | 557.91M | 3.33% | 488,983 | 1.89B |
| 457 | TLRY | Tilray Brands, Inc. | 554.67M | 0.87% | 714,797 | 858.28M |
| 458 | CLPT | ClearPoint Neuro, Inc. | 549.41M | -1.13% | 271,795 | 40.61M |
| 459 | ACHV | Achieve Life Sciences, Inc. | 544.09M | 5.79% | 645,076 | - |
| 460 | RZLT | Rezolute, Inc. | 543.75M | 6.44% | 523,449 | - |
| 461 | ANGO | AngioDynamics, Inc. | 539.17M | 4.57% | 88,040 | 313.73M |
| 462 | EIKN | Eikon Therapeutics, Inc. | 537.60M | 4.42% | 45,360 | - |
| 463 | ASMB | Assembly Biosciences, Inc. | 535.46M | 0.82% | 55,972 | 71.10M |
| 464 | ARVN | Arvinas, Inc. | 532.30M | 1.35% | 219,043 | 89.40M |
| 465 | FLGT | Fulgent Genetics, Inc. | 532.09M | 3.05% | 66,006 | 320.35M |
| 466 | CTEV | Claritev Corporation | 528.65M | 3.16% | 24,752 | 978.76M |
| 467 | CERS | Cerus Corporation | 527.97M | 1.74% | 720,783 | 216.56M |
| 468 | XOMA | XOMA Royalty Corporation | 527.29M | 0.23% | 66,667 | 48.56M |
| 469 | TOI | The Oncology Institute, Inc. | 524.41M | 4.27% | 499,474 | 545.76M |
| 470 | PROK | ProKidney Corp. | 522.56M | -3.89% | 153,519 | 889.00K |
| 471 | KYTX | Kyverna Therapeutics, Inc. | 520.41M | 1.54% | 171,653 | - |
| 472 | STRO | Sutro Biopharma, Inc. | 513.35M | 6.13% | 72,481 | 99.61M |
| 473 | PRTA | Prothena Corporation plc | 513.06M | 2.62% | 117,924 | 57.94M |
| 474 | MCTA | Charming Medical Limited | 504.26M | -0.85% | 4,251,392 | 5.42M |
| 475 | VALN | Valneva SE | 498.24M | -1.48% | 2,549 | 180.25M |
| 476 | CABA | Cabaletta Bio, Inc. | 498.13M | 1.16% | 852,829 | - |
| 477 | NGNE | Neurogene Inc. | 496.81M | 1.88% | 26,883 | 925.00K |
| 478 | SRTA | Strata Critical Medical, Inc. | 487.58M | 1.17% | 261,694 | 228.58M |
| 479 | ARTV | Artiva Biotherapeutics, Inc. | 484.18M | 1.68% | 136,843 | 251.00K |
| 480 | KIDS | OrthoPediatrics Corp. | 482.88M | 2.31% | 52,930 | 243.30M |
| 481 | CCCC | C4 Therapeutics, Inc. | 479.86M | 2.84% | 894,388 | 34.86M |
| 482 | OCGN | Ocugen, Inc. | 479.01M | 2.54% | 1,537,492 | 4.47M |
| 483 | MYGN | Myriad Genetics, Inc. | 478.85M | 9.50% | 661,898 | 829.00M |
| 484 | CTNM | Contineum Therapeutics, Inc. | 474.81M | 6.63% | 75,356 | - |
| 485 | NRC | NRC Health | 462.68M | 2.45% | 20,954 | 138.64M |
| 486 | EOLS | Evolus, Inc. | 461.64M | 4.01% | 191,080 | 301.79M |
| 487 | MOBI | Mobia Medical, Inc. | 458.50M | 0.44% | 5,934 | 38.45M |
| 488 | OVID | Ovid Therapeutics Inc. | 457.27M | 5.60% | 642,886 | 7.12M |
| 489 | FBRX | Forte Biosciences, Inc. | 449.86M | 1.43% | 19,102 | - |
| 490 | BNTC | Benitec Biopharma Inc. | 447.12M | 1.05% | 22,194 | - |
| 491 | EDIT | Editas Medicine, Inc. | 446.57M | 5.43% | 1,743,661 | 38.69M |
| 492 | VTVT | vTv Therapeutics Inc. | 440.54M | 0.50% | 26,014 | 36.84M |
| 493 | PRLD | Prelude Therapeutics Incorporated | 440.35M | 1.37% | 49,014 | 16.72M |
| 494 | IPSC | Century Therapeutics, Inc. | 439.16M | 1.04% | 350,106 | 109.16M |
| 495 | WEAV | Weave Communications, Inc. | 438.80M | 1.38% | 187,618 | 248.72M |
| 496 | VMD | Viemed Healthcare, Inc. | 438.57M | 4.57% | 140,381 | 286.57M |
| 497 | VREX | Varex Imaging Corporation | 437.90M | -1.24% | 40,085 | 857.50M |
| 498 | EBS | Emergent BioSolutions Inc. | 437.54M | 5.87% | 310,324 | 676.80M |
| 499 | PACB | Pacific Biosciences of California, Inc. | 436.40M | 7.25% | 2,740,456 | 160.03M |
| 500 | SGMT | Sagimet Biosciences Inc. | 435.04M | -0.21% | 102,640 | - |